Name: The Investor's DNA - Impacting Biomedical Startups through Venture Capital (en Inglés)
SKU: 66827345
Price: 88126.00 COP
Availability: InStock
Author: Govindaluri, Anand
ISBN: 9789349532113

portada The Investor's DNA - Impacting Biomedical Startups through Venture Capital (en Inglés)

The Investor's DNA - Impacting Biomedical Startups through Venture Capital (en Inglés)

Formato

Libro Físico

Editorial

Verses Kindler Publication

Autor

Govindaluri, Anand

Idioma

Inglés

N° páginas

228

Encuadernación

Tapa Dura

Dimensiones

21.6x14x1.8 cm

ISBN13

9789349532113

The Investor's DNA - Impacting Biomedical Startups through Venture Capital (en Inglés)

Govindaluri, Anand (Autor) · Verses Kindler Publication · Tapa Dura

Libro Nuevo Importado

Envío: 16 a 22 días háb.

$ 176.251$ 88.126

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 88.126

Llega entre el 02 Dic y el 14 Dic a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "The Investor's DNA - Impacting Biomedical Startups through Venture Capital (en Inglés)"

This book traces Anand Govindaluri's journey from biotech researcher to global biomedical venture capitalist. This work discusses the courage to take calculated risks in biomedical investments, drawing on real experiences. It highlights successes and failures, offers insights into venture capital decisions, and presents strategies for effective investment, including international GEM leadership perspectives in pharma, medtech, and digital health. Contributing leaders to this book are: Goran S Malm, Former President, Dell Corp Asia Pacific & GE Medical Systems AsiaD A Prasanna, Chief Patron, Prasanna School of Public Health, Manipal, Author-Innovate Locally to Win Globally, Former MD & CEO, WiproGE IndiaC P Bothra, Chairman, Lyrus Life Sciences, India & Former MD, Medreich, IndiaGourab Mukherjee, Co-Founder & CEO, Aktivolabs, SingaporePatti White, CEO, and Peter Galen, CIO, Hemex Health Inc, USA